RESUMEN
Elastase is a serine protease from the chymotrypsin family of enzymes with the ability to degrade elastin, an important component of connective tissues. Excessive elastin proteolysis leads to a number of pathological diseases. Porcine pancreatic elastase (PPE) is often used for drug development as a model for human leukocyte elastase (HLE), with which it shares high sequence identity. Crystals of PPE were grown overnight using sodium sulfate and sodium acetate at acidic pH. Cross-linking the crystals with glutaraldehyde was needed to resist the soaking procedure with a diethyl N-(methyl)pyridinyl-substituted oxo-ß-lactam inhibitor. Crystals of PPE bound to the inhibitor belonged to the orthorhombic space group P212121, with unit-cell parameters a = 51.0, b = 58.3, c = 74.9â Å, and diffracted to 1.8â Å resolution using an in-house X-ray source.
Asunto(s)
Reactivos de Enlaces Cruzados/farmacología , Glutaral/farmacología , Páncreas/enzimología , Elastasa Pancreática/metabolismo , Animales , Cristalización , Cristalografía por Rayos X , Estabilidad de Enzimas , Elastasa Pancreática/antagonistas & inhibidores , Elastasa Pancreática/química , Sus scrofa , Inhibidores de beta-Lactamasas/química , Inhibidores de beta-Lactamasas/farmacologíaRESUMEN
The 4-oxo-ß-lactams (azetidine-2,4-diones) are potent acylating agents of the human leukocyte elastase (HLE), a neutrophil serine protease that plays a key role in several inflammatory diseases. A novel 4-oxo-ß-lactam containing a N-(4-(phenylsulphonylmethyl)phenyl) group, 3, was designed as a potential mechanism-based inhibitor capable of undergoing elimination of phenylsulphinate upon Ser-195 acylation. Compound 3 was found to be a potent slow-tight binding inhibitor of HLE, presenting a remarkable second-order rate constant of 1.46 x 106 M⻹s⻹ and displaying selectivity over the proteinase 3 and cathepsin G. However, liberation of phenylsulphinate was not observed in the hydrolysis of 3 in both pH 7.4 phosphate buffer and human plasma. The C(max) values of 1207 µg/total blood, 179 µg/g spleen and 106 µg/g lung were determined by HPLC, following a single 30 mg/kg dose of 3 given intraperitoneally to NMRI mice, suggesting that the inhibitor distributes well into tissues. Although being a powerful selective inhibitor of HLE, 4-oxo-ß-lactam 3 has a limited stability, being susceptible to off-target reactions (plasma and liver enzymes).
Asunto(s)
Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacocinética , Elastasa de Leucocito/antagonistas & inhibidores , beta-Lactamas/síntesis química , beta-Lactamas/farmacocinética , Animales , Estabilidad de Medicamentos , Inhibidores Enzimáticos/química , Humanos , Infusiones Parenterales , Masculino , Ratones , Estructura Molecular , beta-Lactamas/químicaRESUMEN
Human leukocyte elastase (HLE) is a serine protease stored in and secreted from neutrophils that plays a determinant role in the pathogenesis of several lung diseases. 4-Oxo-beta-lactams, previously reported as acylating agents of porcine pancreatic elastase, were found to be selective and potent inhibitors of HLE. Structure-activity relationship analysis showed that inhibitory activity is very sensitive to the nature of C-3 substituents, with small alkyl substituents such as a gem-diethyl group improving the inhibitory potency when compared to gem-methyl benzyl or ethyl benzyl counterparts. 4-Oxo-beta-lactams containing a heteroarylthiomethyl group on the para position of an N(1)-aryl moiety afforded highly potent and selective inhibition of HLE, even at a very low inhibitor to enzyme ratio, as shown by the k(on) value of 3.24 x 10(6) M(-1) s(-1) for 6f. The corresponding ortho isomers were 40- to 90-fold less potent.
Asunto(s)
Inhibidores Enzimáticos/farmacología , Elastasa de Leucocito/antagonistas & inhibidores , beta-Lactamas/farmacología , Diseño de Fármacos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Humanos , Cinética , Modelos Moleculares , Estructura Molecular , Relación Estructura-Actividad , beta-Lactamas/síntesis química , beta-Lactamas/químicaRESUMEN
A new class of inhibitors 4-oxo-beta-lactams (azetidine-2,4-diones), containing the required structural elements for molecular recognition, inhibit porcine pancreatic elastase (PPE) but show a dramatically lower reactivity toward hydroxide compared with the analogous inhibitors 3-oxo-beta-sultams. Inhibition is the result of acylation of the active site serine and electron-withdrawing substituents at the N-(4-aryl) position in 3,3-diethyl- N-aryl derivatives increasing the rate of enzyme acylation and generating a Hammett rho-value of 0.65. Compared with a rho-value of 0.96 for the rates of alkaline hydrolysis of the same series, this is indicative of an earlier transition state for the enzyme-catalyzed reaction. Docking studies indicate favorable noncovalent interactions of the inhibitor with the enzyme. Compound 2i, the most potent inhibitor against PPE, emerged as a very potent HLE inhibitor, with a second-order rate for enzyme inactivation of approximately 5 x 10 (5) M (-1) s (-1).
Asunto(s)
Azetidinas/farmacología , Inhibidores Enzimáticos/farmacología , Elastasa Pancreática/antagonistas & inhibidores , Animales , Azetidinas/síntesis química , Azetidinas/química , Sitios de Unión , Diseño de Fármacos , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Modelos Químicos , Modelos Moleculares , Estructura Molecular , Estereoisomerismo , Relación Estructura-Actividad , PorcinosRESUMEN
The presence of a leaving group at C-4 of monobactams is usually considered to be a requirement for mechanism-based inhibition of human leukocyte elastase by these acylating agents. We report that second-order rate constants for the alkaline hydrolysis and elastase inactivation by N-carbamoyl monobactams are independent of the pKa of the leaving group at C-4. Indeed, the effect exerted by these substituents is purely inductive: electron-withdrawing substituents at C-4 of N-carbamoyl-3,3-diethylmonobactams increase the rate of alkaline hydrolysis and elastase inactivation, with Hammett pI values of 3.4 and 2.5, respectively, which indicate the development of a negative charge in the transition-states. The difference in magnitude between these pI values is consistent with an earlier transition-state for the enzymatic reaction when compared with that for the chemical process. These results suggest that the rate-limiting step in elastase inactivation is the formation of the tetrahedral intermediate, and that beta-lactam ring-opening is not concerted with the departure of a leaving group from C-4. Monobactam sulfones emerged as potent elastase inhibitors even when the ethyl groups at C-3, required for interaction with the primary recognition site, are absent. For one such compound, a 1 : 1 enzyme-inhibitor complex involving porcine pancreatic elastase has been examined by X-ray crystallography and shown to result from serine acylation and sulfinate departure from the beta-lactam C-4.
Asunto(s)
Hidróxidos/química , Elastasa Pancreática/antagonistas & inhibidores , beta-Lactamas/química , beta-Lactamas/farmacología , Álcalis/química , Animales , Cristalografía por Rayos X , Activación Enzimática/efectos de los fármacos , Hidrólisis , Cinética , Modelos Moleculares , Estructura Molecular , Elastasa Pancreática/química , Relación Estructura-Actividad , Porcinos , beta-Lactamas/síntesis químicaRESUMEN
Porcine pancreatic elastase (PPE) was crystallized in complex with a novel inhibitor at pH 5 and X-ray diffraction data were collected at a synchrotron source to 1.66 A. Crystals belong to the orthorhombic space group P2(1)2(1)2(1), with unit cell parameters a = 50.25 A, b = 57.94 A and c = 74.69 A. PPE is often used as model for drug target, due to its structural homology with the important therapeutic target human leukocyte elastase (HLE). Elastase is a serine protease that belongs to the chymotrypsin family, which has the ability to degrade elastin, an important component in connective tissues. Excessive elastin proteolysis leads to a number of pathological diseases.